The Grand Merger Of Big Tech And Big Pharma: It’s About The Data

It’s not that Big Pharma and Big Tech were never on the same page, but the Technocrats in both are now obviously seen in a collaboration to capture the health data of all citizens. Technocrats are addicted to data and there is no such thing as “enough.” ⁃ TN Editor

As pandemic countermeasures obliterate the middle class and civil rights, Silicon Valley’s billionaire robber barons are cashing in on the global economic collapse and the rise of the surveillance state.

Now, one of these tech titans — a man with deep ties to the U.S. Central Intelligence Agency (CIA) — has claimed the golden ring: the key contract to manage all the personal, health and financial data that will allow government and industry to keep us in line as they build their New World Order.

Oracle CEO Larry Ellison will curate the vast datasets that house our medical, financial and personal information enabling Big Brother to track and trace our movements, our purchases, our preferences and our vulnerabilities, and use that information to control civil populations, suppress dissent and punish disobedience.

Ellison, whose estimated net worth of $87.7 billion makes him the seventh-richest individual in the world, has just achieved a long-sought milestone. On Dec.15, Oracle, the tech company Ellison founded in 1977 with help from the CIA, issued a press release announcing it “will serve as the CDC’s [U.S. Centers for Disease Control and Prevention] central data repository for all vaccination data in the U.S. This ‘national clearing house’ system will receive data from all U.S. jurisdictions administering vaccinations.”

Almost 20 years since Ellison, in the wake of the 9/11 terrorist attack, offered the government a proposal for a national security database “that collected everything possible to identify someone,” the mogul appears to finally be sitting on cloud nine.

Oracle’s National Electronic Health Records Cloud dates back to the beginnings of the COVID-19 pandemic. In March 2020, a couple of weeks after letting President Trump use his estate near Palm Springs for a $100,000-a-plate golfing fundraiser, Ellison placed a call to the White House. According to a Forbes cover story on Ellison, he “asked Trump if a clearinghouse existed for real-time data about treatment efficacies and outcomes.”

Within a week after the president asked “how much?” and Ellison said, “for free,” the tech titan had brought together a team of Oracle engineers “to build a database and website registering coronavirus cases” and work with the National Institutes of Health (NIH), U.S. Food and Drug Administration (FDA) and other agencies.

The first public acknowledgment of Oracle’s progress came on July 3, 2020, when the NIH’s National Institute for Allergies and Infectious Diseases (NIAID), overseen by Dr. Anthony Fauci, launched the COVID-19 Prevention Trials Network (COVPN), aimed at enrolling thousands of volunteers in large-scale trials for a variety of investigational vaccines and monoclonal antibodies.

Fauci achieved this by merging four existing networks, all researching HIV/AIDS, something they would continue to do. “The network is expected to operate more than 100 clinical trial sites across the United States and internationally,” according to the NIAID press release which also stated “the COVPN website features a customized data collection platform, which Oracle (Redwood Shores, CA) built and donated, to securely identify potential trial participants.”

In August, a paper published by the Johns Hopkins Center for Health Security proposed that the “passive reporting” systems managed by the CDC and FDA ought to be revamped to forge “an active safety surveillance system directed by the CDC that monitors all [COVID-19] vaccine recipients — perhaps by short message service or other electronic mechanisms.”

By September, Operation Warp Speed director Moncef Slaoui was telling the periodical Science: “We’re working super hard on a very active pharmacovigilance system, to make sure that when the vaccines are introduced that we’ll absolutely continue to assess their safety.

In October, Slaoui told the New York Times: “The FDA is proposing that at least 50% of the individuals in the study population have at least two months of follow-up on safety before the vaccines are approved. And secondly, we are working really hard with the FDA and the CDC to make sure we have a very active pharmacovigilance surveillance system to allow us to continue to assess the safety of the vaccines as they are being used in the high risk population.”

And the Wall Street Journal reported in a profile of Slaoui that he’d said “tracking systems will have to be ‘incredibly precise’ to ensure that patients each get two doses of the same vaccine and to monitor them for adverse health effects. Operation Warp Speed has selected the medical-distribution company McKesson and cloud operators Google and Oracle to collect and track vaccine data.”

This marked the first time that Oracle’s role was revealed to have expanded to include Operation Warp Speed.

Oracle Chairman Ellison’s lucrative government arrangements trace back to the data software pioneer’s origins. In 1975, then in his early thirties, Ellison worked on a project for the electronics company Ampex in the Bay area, building a large terabit memory system for the CIA.

Ellison revealed in 2014 that the CIA not only became his firm’s first customer for a “relational database” two years later, but that he adopted the name from a CIA project called Oracle. “The news about our hot little database traveled around the intelligence community pretty quickly,” Ellison was quoted as saying in the 2003 book, “Softwar.” “In a little over six months’ time we had won several deals — the CIA, Navy Intelligence, Air Force Intelligence and the NSA [National Security Agency].”

Read full story here…




Smartphone Apps Under Development For Global Vaccine Passport

And then just like that, the world was transformed into a caste system of “touchables” and “untouchables”. This has absolutely nothing to do with public or your private health, but rather total control over your behavior and person. Technocracy has no capacity for mercy or common sense, and the world will soon feel its iron teeth penetrating the human condition. ⁃ TN Editor

Vaccine passports, hastily ushered in as a byproduct of the COVID-19 pandemic, are expected to become “widely available” during the first half of 2021. “Rest assured, the nerds are on it,” Brian Behlendorf, executive director of Linux Foundation, told CNN Business.1

The Linux Foundation has partnered with IBM, the COVID-19 Credentials Initiative and CommonPass, a digital “health passport,” in order to develop vaccine credential apps that will be applicable globally.

If the initiative is successful, you’ll likely be required to pull up a vaccine certificate on your phone showing when and where you were vaccinated, along with which type of vaccine, in order to get on a plane or attend an indoor event, such as a concert, for starters.

“If we’re successful, you should be able to say: I’ve got a vaccine certificate on my phone that I got when I was vaccinated in one country, with a whole set of its own kind of health management practices … that I use to get on a plane to an entirely different country and then I presented in that new country a vaccination credential so I could go to that concert that was happening indoors for which attendance was limited to those who have demonstrated that they’ve had the vaccine,” Behlendorf said.2

The notion of having to present proof of a voluntary medical procedure in order to travel or attend public events is unprecedented in the U.S., but is being presented as a measure to protect public health. In reality, your freedom to go about your normal, daily life is being threatened, unless you consent to receiving a COVID-19 vaccine. And this may only be the beginning.

What You Need to Know About CommonPass

The Commons Project and the World Economic Forum created the Common Trust Network, which developed the CommonPass app that’s intended to act as a health passport in the near future.

The app allows users to upload medical data such as a COVID-19 test result or proof of vaccination, which then generates a QR code that you will show to authorities as your health passport.3 The proposed common framework “for safe border reopening” around the world involves the following:4

  1. Every nation must publish their health screening criteria for entry into the country using a standard format on a common framework
  2. Each country must register trusted facilities that conduct COVID-19 lab testing for foreign travel and administer vaccines listed in the CommonPass registry
  3. Each country will accept health screening status from foreign visitors through apps and services built on the CommonPass framework
  4. Patient identification is to be collected at the time of sample collection and/or vaccination using an international standard
  5. The CommonPass framework will be integrated into flight and hotel reservation check-in processes

Eventually, the CommonPass framework will be integrated with already existing personal health apps such as Apple Health and CommonHealth. If you want to travel, your personal health record will be evaluated and compared to a country’s entry requirements, and if you don’t meet them, you’ll be directed to an approved testing and vaccination location.

The groundwork for CommonPass was laid out in an April 21, 2020, white paper by The Rockefeller Foundation,5 and is part of the rollout of global surveillance and social control known as “the Great Reset.”

According to CNN, “Airlines including Cathay Pacific, JetBlue, Lufthansa, Swiss Airlines, United Airlines and Virgin Atlantic, as well as hundreds of health systems across the United States and the government of Aruba,” have already partnered with the Common Trust Network and their CommonPass app.6

The CommonPass App, Smart Cards Are Coming

CommonPass is just one example of apps being developed to track your personal health information and convert it into a digital health ID that you’ll need to scan just to go about your daily life. IBM developed the Digital Health Pass, which companies can use to assess everything from coronavirus test results and vaccination to an individual’s temperature.

If you don’t have a cellphone, you won’t be exempt from the need to show your health credentials. Companies that are part of the COVID-19 Credentials Initiative are working on a smart card that acts as a digital health credential that can be easily presented even if you don’t have a smartphone or stable internet connection.7

August 28, 2020, Ireland was among the first to begin a national trial of their new Health Passport Ireland initiative8 to track and display results of COVID-19 testing — and facilitate increased COVID-19 testing for businesses and the public, plus display COVID-19 vaccination status.9

The initiative has since been renamed Health Passport Europe,10 and states the system will soon be used worldwide for international travels. Aside from travel and tourism, Health Passports will be used for health care purposes, events, factories and offices, and even in schools and child care centers.

So, in order to achieve the “freedom” you need to go about your normal, daily life, you only need to get tested or vaccinated for COVID-19, have a health administrator create a Health Passport account in your name, download the app on your phone, receive your COVID-19 test results on your phone (and get retested as required), then display your COVID-19 status and vaccination history whenever it’s requested.

For those who haven’t been tested, Health Passport Europe states that you can still immediately use the technology by downloading the Health Passport Scanner app and using it to scan others whenever needed.

By scanning others to get their COVID-19 status, “It gives great security for you and your family throughout or daily lives, for example when availing of services, whilst travelling, at events, at work and much more.”11

Special Treatment ‘Same as a Mandatory Vaccination’

While many countries have suggested that the COVID-19 vaccine will not be mandated, by giving special privileges to the vaccinated, such as the ability to travel, attend social events or even enter a workplace, it essentially amounts to the same thing.

“As important as vaccination is for all of us: No special treatment for the vaccinated,” Germany’s Interior Minister Horst Seehofer told the Bild am Sonntag newspaper. “Distinguishing between the vaccinated and the not-vaccinated would be the same as a mandatory vaccination.”12

Still, Thomas Mertens, head of Germany’s Standing Commission on Vaccination (STIKO), has stated that vaccine passports may one day be used to grant access to travel, restaurants, concerts and cinemas, and may also be required by certain businesses.

“These are private agreements made by the restaurant owner, the airline and the concert organizer,” he told Die Welt newspaper. “I think something like that is possible. I’m not a lawyer, and at the end of the day lawyers will have to decide.”13

Seehofer, however, stated that while the government couldn’t stop businesses from requiring vaccination of their customers, he was clearly against it: “All I can do is warn against it. Special treatment for the vaccinated would divide society.”14

Meanwhile, Spain, which plans to vaccinate 2.3 million over a 12-week period, is maintaining a register of people who refuse the COVID-19 vaccine and intends to share it with other countries in the European Union.15 While the vaccine is voluntary, citizens are being called for their turn by the national health system, making it easy to track those who refuse.

In 2018, the European Commission drafted a proposal to strengthen cooperation against vaccine preventable diseases, including joint action to increase vaccination coverage, stating, “Vaccination programmes have become increasingly fragile; in the face of low uptake of vaccines, vaccine hesitancy, the increasing cost of new vaccines and shortages in vaccine production and supply in Europe.”16

It appears the sharing of private health information, including who chooses not to receive the COVID-19 vaccine, is part of that joint action.

Tracking and Tracing Are Here

One year ago, it would have been hard to imagine widespread acceptance for cellphone apps that collect your vaccination status and convert it into a health passport you may soon need to present in order to travel or attend recreational events like concerts, or even attend school or go to work. But under the context of a pandemic, it’s suddenly perceived as necessary for public health.

“Vaccinated? Show Us Your App,” reads a New York Times headline from December 13, 2020, which states that United, JetBlue and Lufthansa airlines plan to introduce CommonPass in the coming weeks.17 “It is just the start of a push for digital Covid-19 credentials that could soon be embraced by employers, schools, summer camps and entertainment venues,” the Times added.

Indeed, Dr. Brad Perkins, Commons Project Foundation’s chief medical officer, added, “This is likely to be a new normal need that we’re going to have to deal with to control and contain this pandemic.”

Getting health passports to become a new normal has, in fact, been part of the plan all along for the Commons Project, which began developing software that tracks medical data well before the COVID-19 pandemic.18 “But spikes in virus cases around the world this spring accelerated its work,” The New York Times reported.

It’s Not About Infectious Disease

Now partnered with the World Economic Forum, CommonPass represents the beginning stage of mass tracking and tracing, under the guise of keeping everyone safe from infectious disease.

It is part and parcel of the Great Reset and the fourth industrial revolution, the nuts and bolts of which boil down to transhumanism. In years past, this plan was referred to as a “new world order” or “one world order.” All of these terms, however, refer to an agenda that has the same ultimate goal.

As explained by journalist James Corbett, for those who forgot about what the New World Order was/is all about, it’s “centralization of control into fewer hands, globalization [and] transformation of society through Orwellian surveillance technologies.”19

In other words, it’s technocracy, where we the people know nothing about the ruling elite while every aspect of our lives is surveilled, tracked and manipulated for their gain. The tracking and tracing of COVID-19 test results and vaccination are setting the stage for biometric surveillance, tracking and tracing, which will eventually be tied in with all your other medical records, digital ID, digital banking and a social credit system.

What can you do? Getting informed and sharing your knowledge is the first step to protecting your freedom. Next, learn the role of your local sheriff, who should safeguard your Constitutional rights and protect your civil liberties against unlawful government overreach.

The most important part is to contact your local sheriff and urge him or her to learn about the Constitutional Sheriffs and Peace Officers Association (CSPOA).

The goal is to create a partnership between the people, the sheriff and the local law enforcement chiefs to make sure county sheriffs are trained on Constitutional rights and their own role as guardians of the Constitution and protectors of civil liberties, so they will no longer enforce unlawful, unconstitutional orders, whatever they might be.

Read full story here…




FDA Approves GMO Pigs For Food, Drugs, Transplants

The rationale that genetically modified foods are substantially equivalent to their non-GMO counterparts has opened Pandora’s box to do to the animal kingdom what has already being done in the plant kingdom. Humanity itself is the final frontier for  genetic modification. ⁃ TN Editor

Genetically engineering pigs so they lack a certain sugar on the surface of their cells that triggers meat allergies or organ rejection won approval from the Food and Drug Administration Monday. The regulatory clearance — the first of an intentional genomic alteration in a product with both food and medical uses — means the animals could be safer sources of not just food but also treatments such as the blood-thinner heparin.

“Today’s first ever approval of an animal biotechnology product for both food and as a potential source for biomedical use represents a tremendous milestone for scientific innovation,” FDA Commissioner Stephen Hahn said in a statement.

There have been four previous approvals for such genetic engineering in animals, three for biomedical purposes and one for food, but none for both biomedicine and food, Steven Solomon, director of the FDA’s Center for Veterinary Medicine, said in a conference call with reporters.

GalSafe pigs, named for their lack of detectable alpha-gal sugar, could potentially provide tissues and organs for patients without the danger of rejection caused by the presence of the sugar in cross-species procedures known as xenografts or xenotransplantation. Alpha-gal is considered a primary cause of rejection, Solomon said, but he was hesitant to say it is the only source.

“I think that people need to be careful,” Solomon said. “That’s why in part, it’s going to require further evaluation for xenotransplantation, xenograft, or the other activities by the medical products centers and FDA.”

People with Alpha-gal syndrome, a condition that causes mild to severe allergic reactions to alpha-gal sugar found in the red meats beef, pork, and lamb, might also benefit. The allergic reaction, recently identified in the United States, occurs after a Lone Star tick bites and then transmits alpha-gal sugar into a person’s body. Some people develop an immune reaction that later erupts into mild to severe allergic responses after eating the alpha-gal sugar in meat.

The FDA did not test food safety specifically for people who have the syndrome, nor did the agency evaluate the pigs for use in transplantation or implantation into humans. Any developers hoping to make medical products based on GalSafe pigs would have to seek approval from the FDA before any organs, implants, or drugs could be used in human medicine.

Read full story here…




WEF Reset: Pandemic Could Usher In Universal Health Coverage

Data-driven or “evidence-based” medicine is a purely Technocrat concept at the center of herd management principles. The WEF sees Telemedicine and AI as the ultimate dispenser of health services to an unsuspecting population where personal doctor-patient relationships will not be allowed. ⁃ TN Editor

The coronavirus disease (COVID-19) pandemic which started as an outbreak in one country, and very quickly travelled around the world, makes a strong case for investment in global public health and has resurrected the debate of universal health coverage (UHC).

An estimated 400 million people around the world lack access to basic health services. Each year, close to 100 million people are pushed into extreme poverty because they have to cover their own health costs. These numbers have increased with COVID-19 and will continue to increase as people lose jobs, health insurance and health expenditures rise due to COVID-19 related spending on testing, treatment and vaccines.

The shift to value-based healthcare (VBHC) is fundamental to achieving UHC objectives of quality healthcare, financial protection and equitable access to healthcare. These systems are already stretched, riddled with chronic diseases and complex morbidities that have been further exacerbated by COVID-19.

It is crucial to optimize the efficiency of health systems and deliver patient-centric care where the focus is on health outcomes that truly matter to the patient and society. To achieve this, here are the three ways VBHC can enable UHC in a post-pandemic recovery world.

1. Data-driven approaches optimise care delivery

Throughout the global effort to mitigate the spread of COVID-19, many traditional services have rapidly pivoted towards innovative remote access care. The inherent inertia in legacy healthcare systems was swiftly superseded by an urgent need to facilitate remote healthcare delivery, which has created a digital health boom.

The value of digital health in advancing the UHC agenda has increasingly been validated by support from the World Health Organization who agreed on a mandate for digital health as a tool for advancing UHC.

In particular, Telemedicine has allowed for greater levels of doctor-patient engagement regardless of location, thereby significantly increasing the geographical reach of healthcare personnel. Other capabilities of digital health include e-learning and mobile-learning tools that can drive greater preventative and health-seeking behaviours consistent with UHC.

The value of data captured by these elements gives greater clarity to the ‘digital divide’, highlighting how underserved populations lack the tools to engage in appropriate health-seeking behaviours. This allows for targeted approaches to care delivery for patients living in digital deserts – enabling them to access care through alternative models such as mobile clinics.

This data-driven approach to optimising care delivery is consistent with VBHC as it focuses on improving outcomes. WHO Director-General Dr. Tedros Adhanom Ghebreyesus states that: “harnessing the power of digital technologies is essential for achieving universal health coverage.”

COVID-19 has accelerated this digital transition and we must harness the power of data to identify key pain points and blind spots in our healthcare delivery models, and expand coverage to more of the world’s population.

2. Better healthcare access and outcomes improves population health

Despite many countries nominally providing UHC and improving access, there are still many problems related to quality of care and missed opportunities for improving outcomes. To maximise the efforts that improve health coverage, we must move beyond access and benefits packages to an emphasis on quality of care and health outcomes – a defining pillar of VBHC.

Digital health and data-driven care are increasingly recognised as drivers of UHC and we must ensure that these tools involve systematic collection and analysis of comprehensive health-outcome data. By meticulously tracking health outcomes for appropriately segmented groups we can measure the impact of health interventions independent of access.

These models have been embraced by several countries, and it’s expected that the seismic shift to digital health in the aftermath of COVID-19 will increase take-up of value-based decision-making. Rwanda is often touted as a developing country with a noteworthy healthcare system, which includes significant use of computerized medical records and comparatively high healthcare outcomes.

Read full story here…




Dentists: ‘Mask Mouth’ Can Lead To Strokes, Heart Attacks

One dentist says,  “50% of his patients are suffering from negative health issues due to mask-wearing.” No, it’s not just about bad breath. Oral inflammation and excessive bacteria are well-known killers.  ⁃ TN Editor

Dentists are warning about the health issues tied to prolonged use of a mask to stop the spread of the coronavirus.

They said dental problems associated with “mask mouth,” including gum disease, could lead to serious complications.

“Gum disease — or periodontal disease — will eventually lead to strokes and an increased risk of heart attacks,” Marc Sclafani, a dentist and co-founder of One Manhattan Dental, told the New York Post about “mask mouth,” which is increasingly causing inflammation and gum disease among patients.

Another dentist and co-founder at One Manhattan Dental, Rob Ramondi, said 50% of his patients are suffering from negative health issues due to mask-wearing.

“We’re seeing inflammation in people’s gums that have been healthy forever, and cavities in people who have never had them before,” Ramondi said. “About 50% of our patients are being impacted by this, [so] we decided to name it ‘mask mouth’ — after ‘meth mouth.’”

“Meth mouth” is a term used to describe poor oral hygiene typically associated with chronic meth users.

The dentists said that the face coverings increase mouth dryness and contribute to a buildup of bad bacteria.

“People tend to breathe through their mouth instead of through their nose while wearing a mask,” Sclafani said. “The mouth breathing is causing the dry mouth, which leads to a decrease in saliva — and saliva is what fights the bacteria and cleanses your teeth.”

Sclafani suggested those who have no choice but to wear masks can drink more water, cut down on caffeine, snag a humidifier to moisten the air, use an alcohol-free mouthwash, scrape their tongue, and refrain from smoking.

Wearing face coverings to stem the spread of the coronavirus has become a contentious issue across the United States, with some states and cities imposing mandatory face mask requirements, while others have filed lawsuits to defy those precautions.

Read full story here…




Harris County Public Health Department Goes Door-To-Door To Collect Blood Samples

Contact Tracing is morphing into a generalized population control program where random homeowners will get a knock on the door to ask very personal questions and solicit blood samples. ⁃ TN Editor

Harris County Public Health will conduct a survey to continue studies on the COVID-19 pandemic.

Representatives with HCPH will go door-to-door to randomly selected homes throughout the county, collecting blood samples to determine the presence of COVID-19 antibodies.

“In an effort to better understand how many people in Harris County may have already been infected with COVID-19, officials with Harris County Public Health (HCPH) will be conducting a survey of randomly selected homes,” Harris County Public Health stated in a release. “The survey will identify people infected in the past with COVID-19 by the presence of antibodies, proteins the body’s immune system makes to fight infections. County residents agreeing to participate in the survey will be tested for the presence of these antibodies.”

https://youtu.be/1VPsUfH29Kg

HCPH officials will begin visiting randomly selected homes starting from Nov. 15 to Dec. 15 from the hours of 8 a.m. – 5 p.m. HCPH staff will be wearing yellow Harris County Public Health vests and present proper identification. They will also be wearing PPE.

“Participants will be asked to provide answers to survey questions and provide blood samples that will be tested for the presence of antibodies. Once completed, the survey will assist policymakers and health experts understand how vulnerable the community remains to the virus, and how frequently asymptomatic or mild cases occur,” Harris County Public Health stated.

According to HCPH, officials’ goals of the survey are to:

– Understand what caused COVID-19 to spread in certain areas.

– Understand how COVID-19 has spread in Harris County.

– Understand how COVID-19 transmission and infection rates differ among communities.

– Determine the effectiveness of containment strategies that have been utilized during the pandemic.

– Identify the percentage of Harris County residents infected with COVID-19 with no symptoms, and

– Improve public health messaging to help stop the spread of COVID-19.

Read full story here…




CDC Will Map COVID-19 But Suspends Tracking Of Influenza

A single paragraph has been added to the CDC’s website page titled, U.S. Influenza Surveillance System: Purpose and Methods, stating that because of COVID-19, it will suspend data collection for regular influenza during the 2020-2021 flu season.

Thus, it will be impossible to statistically analyze the relative differences between COVID and influenza. It will also likely result in reporting some cases of influenza as COVID, when they are not. Thus, all attention will be given to COVID, magnifying cases to fit the pandemic narrative.

According to the CDC’s website:

3. Summary of the Geographic Spread of Influenza

State and territorial health departments report the estimated level of geographic spread of influenza activity in their jurisdictions each week through the State and Territorial Epidemiologists Report. This level does not measure the severity of influenza activity; low levels of influenza activity occurring throughout a jurisdiction would result in a classification of “widespread”. Jurisdictions classify geographic spread as follows:

    • No Activity: No laboratory-confirmed cases of influenza and no reported increase in the number of cases of ILI.
    • Sporadic: Small numbers of laboratory-confirmed influenza cases or a single laboratory-confirmed influenza outbreak has been reported, but there is no increase in cases of ILI.
    • Local: Outbreaks of influenza or increases in ILI cases and recent laboratory-confirmed influenza in a single region of the state.
    • Regional: Outbreaks of influenza or increases in ILI and recent laboratory confirmed influenza in at least two but less than half the regions of the state with recent laboratory evidence of influenza in those regions.
    • Widespread: Outbreaks of influenza or increases in ILI cases and recent laboratory-confirmed influenza in at least half the regions of the state with recent laboratory evidence of influenza in the state.

Due to the ongoing COVID-19 pandemic, this system will suspend data collection for the 2020-21 influenza season. Data from previous seasons are available on FluView Interactive.

 




Biosensor Chips To Test DNA For COVID-19 By 2021

This project is funded by IARPA, the intelligence community’s equivalent to the military’s DARPA. It delivers on-the-spot DNA sequencing and analysis of COVID-19 and other diseases. This will replace all other COVID tests and require DNA collection from every human on earth. ⁃ TN Editor

Roswell Biotechnologies, Inc., the leader in molecular electronics sensor chips, and imec, a world-leading research and innovation hub in nanoelectronics and digital technologies, announced today a partnership to develop the first commercially available molecular electronics biosensor chips. These chips are the brains behind Roswell Technologies’ powerful new platform for DNA sequencing, to support precision medicine, molecular diagnostics, rapid infectious disease testing, and DNA data storage.

“The urgent need for a new generation of rapid, low-cost, consumer surveillance and diagnostics tools has been made extremely clear in the current COVID-19 pandemic,” said Roswell President & CEO Paul Mola. “In that area, the Roswell molecular electronic platform will transform the way infectious diseases are detected, with powerful new capabilities that enable, rapid screening of many infectious diseases at once, or many viral strains, with portable or handheld devices.”

The Roswell platform is the first to deliver the power of molecular electronic sensing, to support a full spectrum of DNA sequencing and biosensing applications. This includes the spectrum of tests necessary for the detection and containment of infectious diseases, such as COVID-19, including sequencing, nucleic acid detection, antigen detection and antibody detection. The platform was also designed with the scalability to provide the solution for rapid, low-cost whole genome sequencing in precision medicine, for treating cancer and other diseases, as well as for reading massive amounts of digital data stored in DNA, which is envisioned as the future of archiving data at the global scale.

Molecular electronic sensor chips integrate single molecules as electrical sensor elements on standard semiconductor chips, making electronic biosensor devices massively scalable. While electronic biosensors have seen gradual adoption in DNA sequencing and other areas of testing, there have been no major innovations in the basic sensor technology. The Roswell molecular electronics sensors represent an entirely new class of sensors, specifically designed to be maximally compatible with modern CMOS chip technology, delivering a technological breakthrough that significantly increases performance and lowers costs. This advance allows low-cost, high speed biomedical tests, including DNA sequencing and other forms of biomarkers sensing essential to modern medical diagnostics, to be deployed on simple portable or handheld devices.

“Although molecular electronics has long been hailed as a scientific breakthrough, its commercial viability required the technology to be put on a standard semiconductor chip,” said Roswell Chief Science Officer Dr. Barry Merriman. “One of the significant hurdles to commercializing molecular electronics is the need for costly customized solutions for large scale manufacturing. Imec has overcome those challenges by utilizing state-of-the-art semiconductor manufacturing technology coupled with its deep experience in biosensor technology to commercialize molecular electronics using standard tools. We are excited to be partnering with imec on this effort.”

Imec and Roswell have successfully completed key proof-of-concept work and are now focused on final process development. The initial products are expected to be commercially available in 2021.

“Building on its leadership in advanced process development for the semiconductor industry, imec has pushed the limits of what is possible. This next-generation sensor, poised to disrupt bio-sensing, benefits from our broad expertise to solve the manufacturing hurdles,” said Dr. Ashesh Ray Chaudhuri,  team leader of life science technologies at imec.

Dr. Simone Severi, program director for life science technologies at imec, added, “Our partnership with Roswell is a great example of how imec is leveraging its leadership in state-of-the-art semiconductor manufacturing technology to make next-generation life-science instrumentation possible. We are very excited to collaborate with Roswell on the integration of their molecular electronics sensor and developing the fastest route to achieving large scale commercial manufacturing of their sensor chips. It is especially motivating to use our skills to make a direct impact in important areas of medicine, such as genome sequencing and infectious disease monitoring, as well as to open up new sectors such as DNA storage of Exabyte scale DNA.”

About Roswell Biotechnologies

Roswell Biotechnologies, Inc. is the leading developer of molecular electronics for chip-based DNA sequencing and biosensing. The company’s platform technology reduces the cost and complexity of DNA sequencing to address large markets in infectious disease surveillance and containment, precision medicine, molecular diagnostics, and DNA digital data storage.  Roswell Biotechnologies’ patented molecular electronics biosensor chip is the first to integrate molecular elements into semiconductor chips, by combining the latest advances in sensors and nanotechnology, to fundamentally advance the application of DNA sequencing and biosensing. Founded in 2014, the privately held company is headquartered in San Diego, California.

About imec

Imec is a world-leading research and innovation hub in nanoelectronics and digital technologies. The combination of our widely acclaimed leadership in microchip technology and profound software and ICT expertise is what makes us unique. By leveraging our world-class infrastructure and local and global ecosystem of partners across a multitude of industries, we create groundbreaking innovation in application domains such as healthcare, smart cities and mobility, logistics and manufacturing, energy and education.

As a trusted partner for companies, start-ups and universities we bring together more than 4,500 brilliant minds from over 95 nationalities. Imec is headquartered in Leuven, Belgium and has distributed R&D groups at a number of Flemish universities, in the NetherlandsTaiwanUSA, and offices in ChinaIndia and Japan. In 2019, imec’s revenue (P&L) totaled 640 million euro. Further information on imec can be found at www.imec-int.com.

Imec is a registered trademark for the activities of IMEC International (a legal entity set up under Belgian law as a “stichting van openbaar nut”), imec Belgium (IMEC vzw supported by the Flemish Government), imec the Netherlands (Stichting IMEC Nederland, part of Holst Centre which is supported by the Dutch Government), imec Taiwan (IMEC Taiwan Co.) and imec China (IMEC Microelectronics (Shanghai) Co. Ltd.) and imec India (Imec India Private Limited), imec Florida (IMEC USA nanoelectronics design center).

SOURCE Roswell Biotechnologies, Inc.

Read full story here…

 




UN Pushes Universal Health Care To Fight COVID-19

To help the world better deal with pandemics, the United Nations is calling for a Universal Health Care system that would span all nations and be controlled by the UN itself. This is all in the name of furthering the Sustainable Development Goals (SDGs) that the UN created to usher in Sustainable Development, aka Technocracy. ⁃ TN Editor

UN Secretary-General António Guterres has urged governments to speed up and scale up their investment in universal health coverage (UHC) and stronger health systems, in order to tackle the COVID-19 pandemic and prepare for future crises. The policy brief also addresses the health impact of COVID-19 on refugees and internally displaced persons (IDPs). 

In a video message to launch the brief titled, ‘COVID-19 and Universal Health Coverage,’ Guterres said the “world was not prepared” for the COVID-19 pandemic, and underinvestment in health care can have devastating impacts on societies and economies. He said the pandemic also revealed “yawning gaps in social protection and major structural inequalities within and between countries.” The brief argues that countries could more effectively and efficiently address the COVID-19 crisis through a UHC system, and underscores the critical linkages between public health and broader economic and societal resilience.

The policy brief cautions that the effects of the pandemic could “seriously impair or reverse progress towards the SDGs.” Each health-related SDG target is expected to go backwards. For instance, the brief states that reductions in maternal and child health interventions, such as immunization, could lead to over 250,000 additional child deaths and 12,000 maternal deaths in six months in 118 countries. If lockdowns continue for at least six months in 114 low- and middle-income countries, an additional 31 million cases of gender-based violence “can be expected to occur.” The brief also documents potential negative impacts on malaria deaths, AIDS-related illnesses, and noncommunicable diseases (NCDs).

In addition, the pandemic is affecting other SDGs. The global recession is expected to lead to the first rise in global extreme poverty since 1998, pushing 70 to 100 million people into extreme poverty and “wiping out progress made since 2017.” A large share of the new extreme poor will be in South Asia, and one-third is projected to be concentrated in Sub-Saharan Africa.

The brief presents five major recommendations:

  • Urgently control COVID-19 transmission, including with stronger public health measures to reduce local transmission to zero, facilitate universal provision for COVID-19 testing, isolating, and contract tracing, and ensure access to care for COVID-19 patients to reduce deaths;
  • Protect delivery of other essential services;
  • Massively expand access to new rapid diagnostics and treatments, and ensure future COVID-19 vaccines are a global public good with equitable access for everyone, everywhere, including through fully funding the Access to COVID-19 Tools Accelerator (ACT-Accelerator) and urgently addressing the spread of misinformation about vaccine safety;
  • Achieve UHC by investing in core health systems functions that are fundamental to protecting and promoting health and well-being, and suspending user fees for COVID-19 and other essential health care; and
  • Strengthen national and global pandemic preparedness and aim for healthy societies.

The brief shares examples of good practice in addressing the health impact of COVID-19 on refugees and IDPs. Rwanda has included urban refugees in Kigali in its national health insurance scheme. Peru approved temporary health coverage for refugees and migrants suspected of or testing positive for COVID-19. In Argentina, Chile, and Peru, to address the socio-economic impact of COVID-19 on those who have been forcibly displaced, the governments have allowed foreign-trained refugee doctors, nurses, and others with medical training to work during the COVID-19 response. Ireland’s Medical Council announced that refugees and asylum-seekers with medical training can provide medical support, including as healthcare assistants. The Government of South Africa has provided financial support for foreign-owned businesses, including those owned by refugees.

The brief concludes that UHC can be a “powerful social equalizer” and a catalyst for economic growth. It underscores that systems that sustain progress towards UHC through a whole-population perspective are better positioned to respond to disease outbreaks like COVID-19.

Read full story here…




Flashback: U.S. Participated In Extremist ‘One World, One Health’

The “challenges that undoubtedly lie ahead” were all wildly speculative and smacked of environmental extremism, but why did the CDC and Department of Agriculture participate in this craziness? Both of these agencies should have condemned these proceedings rather than embraced them.

Was our own government selling America down the river without so much as a press release to tell us so? Today’s scope of the COVID panic and the ‘Great Reset’ is coming into focus: it’s all about the entire basket of policies emanating from the United Nations over the last 30 years under the umbrella of Sustainable Development, aka Technocracy. ⁃ TN Editor

About “One World, One Health”

Health experts from around the world met on September 29, 2004 for a symposium focused on the current and potential movements of diseases among human, domestic animal, and wildlife populations organized by the Wildlife Conservation Society and hosted by The Rockefeller University. Using case studies on Ebola, Avian Influenza, and Chronic Wasting Disease as examples, the assembled expert panelists delineated priorities for an international, interdisciplinary approach for combating threats to the health of life on Earth.

The product—called the “Manhattan Principles” by the organizers of the “One World, One Health” event, lists 12 recommendations (see below) for establishing a more holistic approach to preventing epidemic / epizootic disease and for maintaining ecosystem integrity for the benefit of humans, their domesticated animals, and the foundational biodiversity that supports us all.

Representatives from the World Health Organization; the UN Food and Agriculture Organization; the Centers for Disease Control and Prevention; the United States Geological Survey National Wildlife Health Center; the United States Department of Agriculture; the Canadian Cooperative Wildlife Health Centre; the Laboratoire Nationale de Sante Publique of Brazzaville, Republic of Congo; the IUCN Commission on Environmental Law; and the Wildlife Conservation Society were among the many participants.

The Manhattan Principles on “One World, One Health”

Recent outbreaks of West Nile Virus, Ebola Hemorrhagic Fever, SARS, Monkeypox, Mad Cow Disease and Avian Influenza remind us that human and animal health are intimately connected. A broader understanding of health and disease demands a unity of approach achievable only through a consilience of human, domestic animal and wildlife health – One Health. Phenomena such as species loss, habitat degradation, pollution, invasive alien species, and global climate change are fundamentally altering life on our planet from terrestrial wilderness and ocean depths to the most densely populated cities. The rise of emerging and resurging infectious diseases threatens not only humans (and their food supplies and economies), but also the fauna and flora comprising the critically needed biodiversity that supports the living infrastructure of our world. The earnestness and effectiveness of humankind’s environmental stewardship and our future health have never been more clearly linked. To win the disease battles of the 21st Century while ensuring the biological integrity of the Earth for future generations requires interdisciplinary and cross-sectoral approaches to disease prevention, surveillance, monitoring, control and mitigation as well as to environmental conservation more broadly.

We urge the world’s leaders, civil society, the global health community and institutions of science to:

1. Recognize the essential link between human, domestic animal and wildlife health and the threat disease poses to people, their food supplies and economies, and the biodiversity essential to maintaining the healthy environments and functioning ecosystems we all require.

2. Recognize that decisions regarding land and water use have real implications for health. Alterations in the resilience of ecosystems and shifts in patterns of disease emergence and spread manifest themselves when we fail to recognize this relationship.

3. Include wildlife health science as an essential component of global disease prevention, surveillance, monitoring, control and mitigation.

4. Recognize that human health programs can greatly contribute to conservation efforts.

5. Devise adaptive, holistic and forward-looking approaches to the prevention, surveillance, monitoring, control and mitigation of emerging and resurging diseases that take the complex interconnections among species into full account.

6. Seek opportunities to fully integrate biodiversity conservation perspectives and human needs (including those related to domestic animal health) when developing solutions to infectious disease threats.

7. Reduce the demand for and better regulate the international live wildlife and bushmeat trade not only to protect wildlife populations but to lessen the risks of disease movement, cross-species transmission, and the development of novel pathogen-host relationships. The costs of this worldwide trade in terms of impacts on public health, agriculture and conservation are enormous, and the global community must address this trade as the real threat it is to global socioeconomic security.

8. Restrict the mass culling of free-ranging wildlife species for disease control to situations where there is a multidisciplinary, international scientific consensus that a wildlife population poses an urgent, significant threat to human health, food security, or wildlife health more broadly.

9. Increase investment in the global human and animal health infrastructure commensurate with the serious nature of emerging and resurging disease threats to people, domestic animals and wildlife. Enhanced capacity for global human and animal health surveillance and for clear, timely information-sharing (that takes language barriers into account) can only help improve coordination of responses among governmental and nongovernmental agencies, public and animal health institutions, vaccine / pharmaceutical manufacturers, and other stakeholders.

10. Form collaborative relationships among governments, local people, and the private and public (i.e.- non-profit) sectors to meet the challenges of global health and biodiversity conservation.

11. Provide adequate resources and support for global wildlife health surveillance networks that exchange disease information with the public health and agricultural animal health communities as part of early warning systems for the emergence and resurgence of disease threats.

12. Invest in educating and raising awareness among the world’s people and in influencing the policy process to increase recognition that we must better understand the relationships between health and ecosystem integrity to succeed in improving prospects for a healthier planet.

It is clear that no one discipline or sector of society has enough knowledge and resources to prevent the emergence or resurgence of diseases in today’s globalized world. No one nation can reverse the patterns of habitat loss and extinction that can and do undermine the health of people and animals. Only by breaking down the barriers among agencies, individuals, specialties and sectors can we unleash the innovation and expertise needed to meet the many serious challenges to the health of people, domestic animals, and wildlife and to the integrity of ecosystems. Solving today’s threats and tomorrow’s problems cannot be accomplished with yesterday’s approaches. We are in an era of “One World, One Health” and we must devise adaptive, forward-looking and multidisciplinary solutions to the challenges that undoubtedly lie ahead.

Read full story here…